Agilent Technologies Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Agilent Technologies de 7.5% y 5.1% por año respectivamente. Se prevé que el BPA crezca en un 8.5% al año. Se espera que la rentabilidad financiera sea de 24.8% en 3 años.
Información clave
7.5%
Tasa de crecimiento de los beneficios
8.5%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Life Sciences | 16.8% |
| Tasa de crecimiento de los ingresos | 5.1% |
| Rentabilidad financiera futura | 24.8% |
| Cobertura de analistas | Good |
| Última actualización | 10 Jun 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Is Agilent A Buy Before Earnings? Examining The Pros And Cons
May 23Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?
May 22
Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price
May 07These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well
Apr 05Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold
Mar 12Agilent Technologies Hit A Homerun
Dec 24Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)
Dec 08Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly
Dec 07Agilent Technologies: Looking Undervalued Heading Into Earnings
Nov 17Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Oct 26Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart
Sep 26Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?
Sep 08Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly
Aug 21Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
Jul 23Agilent Technologies - A Wealth Compounder 30% Below Its Highs
Jul 13Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today
Jul 10What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?
May 28Agilent Technologies Stock: Starting To Look Appealing
May 25These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Safely
Apr 17Calculating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Apr 03Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today
Mar 21Agilent Technologies, Inc.'s (NYSE:A) CEO Compensation Is Looking A Bit Stretched At The Moment
Mar 09Agilent Technologies declares $0.225 dividend
Feb 22Fluor's unit gets contract to expand Agilent's manufacturing facility in Colorado
Feb 16Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?
Jan 30Agilent Technologies: A Proven Track Record Of Shareholder Value Creation, Hold
Jan 16Agilent to acquire Avida for cancer research
Jan 04Agilent Technologies (NYSE:A) Has A Rock Solid Balance Sheet
Dec 30Agilent's liquid biopsy test gets FDA nod for companion diagnostic test to Mirati's Krazati
Dec 13Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 10/31/2026 | 7,319 | 1,549 | 1,730 | 2,048 | 13 |
| 10/31/2025 | 6,845 | 1,425 | 1,546 | 1,874 | 17 |
| 10/31/2024 | 6,460 | 1,310 | 1,333 | 1,704 | 16 |
| 4/30/2024 | 6,591 | 1,242 | 1,538 | 1,896 | N/A |
| 1/31/2024 | 6,735 | 1,236 | 1,649 | 1,961 | N/A |
| 10/31/2023 | 6,833 | 1,240 | 1,474 | 1,772 | N/A |
| 7/31/2023 | 6,994 | 1,133 | 1,420 | 1,704 | N/A |
| 4/30/2023 | 7,040 | 1,351 | 1,183 | 1,468 | N/A |
| 1/31/2023 | 6,930 | 1,323 | 1,061 | 1,353 | N/A |
| 10/31/2022 | 6,848 | 1,254 | 1,021 | 1,312 | N/A |
| 7/31/2022 | 6,659 | 1,328 | 1,022 | 1,305 | N/A |
| 4/30/2022 | 6,527 | 1,263 | 1,058 | 1,313 | N/A |
| 1/31/2022 | 6,445 | 1,205 | 1,280 | 1,502 | N/A |
| 10/31/2021 | 6,319 | 1,210 | 1,297 | 1,485 | N/A |
| 7/31/2021 | 6,142 | 990 | 1,268 | 1,421 | N/A |
| 4/30/2021 | 5,817 | 925 | 1,253 | 1,377 | N/A |
| 1/31/2021 | 5,530 | 810 | 1,092 | 1,218 | N/A |
| 10/31/2020 | 5,339 | 719 | 802 | 921 | N/A |
| 7/31/2020 | 5,223 | 691 | 736 | 858 | N/A |
| 4/30/2020 | 5,236 | 683 | 665 | 810 | N/A |
| 1/31/2020 | 5,236 | 764 | 598 | 749 | N/A |
| 10/31/2019 | 5,163 | 1,071 | 865 | 1,021 | N/A |
| 7/31/2019 | 5,090 | 1,072 | 917 | 1,079 | N/A |
| 4/30/2019 | 5,019 | 1,117 | 887 | 1,034 | N/A |
| 1/31/2019 | 4,987 | 1,140 | 929 | 1,085 | N/A |
| 10/31/2018 | 4,914 | 316 | 910 | 1,087 | N/A |
| 7/31/2018 | 4,809 | 298 | 804 | 1,003 | N/A |
| 4/30/2018 | 4,720 | 237 | 825 | 1,034 | N/A |
| 1/31/2018 | 4,616 | 196 | N/A | 988 | N/A |
| 10/31/2017 | 4,472 | 684 | N/A | 889 | N/A |
| 7/31/2017 | 4,394 | 633 | N/A | 835 | N/A |
| 4/30/2017 | 4,324 | 582 | N/A | 801 | N/A |
| 1/31/2017 | 4,241 | 509 | N/A | 798 | N/A |
| 10/31/2016 | 4,202 | 462 | N/A | 793 | N/A |
| 7/31/2016 | 4,126 | 476 | N/A | 800 | N/A |
| 4/30/2016 | 4,096 | 465 | N/A | 714 | N/A |
| 1/31/2016 | 4,040 | 466 | N/A | 643 | N/A |
| 10/31/2015 | 4,038 | 438 | N/A | 1,322 | N/A |
| 7/31/2015 | 4,046 | 306 | N/A | 1,245 | N/A |
| 4/30/2015 | 4,041 | 256 | N/A | 1,165 | N/A |
| 1/31/2015 | 4,066 | 204 | N/A | 1,307 | N/A |
| 10/31/2014 | 4,048 | 232 | N/A | 731 | N/A |
| 7/31/2014 | 4,723 | 435 | N/A | 924 | N/A |
| 4/30/2014 | 5,366 | 540 | N/A | 1,111 | N/A |
| 1/31/2014 | 6,110 | 666 | N/A | 1,101 | N/A |
| 10/31/2013 | 3,894 | 225 | N/A | 1,152 | N/A |
| 7/31/2013 | 6,831 | 938 | N/A | 1,260 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (7.5% al año) de A es superior a la tasa de ahorro (2.4%).
Beneficios vs. Mercado: Se prevé que los beneficios (7.5% al año) de A crezcan menos que el mercado US (14.8% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de A crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (5.1% al año) de A crezcan más despacio que el mercado de US (8.7% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 5.1% al año) de A crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de A sea alta dentro de 3 años (24.8%)